0001140361-14-037288.txt : 20141003
0001140361-14-037288.hdr.sgml : 20141003
20141003143521
ACCESSION NUMBER: 0001140361-14-037288
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141002
FILED AS OF DATE: 20141003
DATE AS OF CHANGE: 20141003
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OncoMed Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001302573
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 383572512
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 800 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 650-995-8200
MAIL ADDRESS:
STREET 1: 800 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lewicki John A.
CENTRAL INDEX KEY: 0001553352
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35993
FILM NUMBER: 141139383
MAIL ADDRESS:
STREET 1: C/O ONCOMED PHARMACEUTICALS, INC.
STREET 2: 800 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
4
1
doc1.xml
FORM 4
X0306
4
2014-10-02
0
0001302573
OncoMed Pharmaceuticals Inc
OMED
0001553352
Lewicki John A.
C/O ONCOMED PHARMACEUTICALS, INC.
800 CHESAPEAKE DRIVE
REDWOOD CITY
CA
94063
0
1
0
0
EVP & Chief Scientific Officer
Common Stock
2014-10-02
4
M
0
5809
1.43
A
26411
D
Common Stock
2014-10-02
4
S
0
5809
20.00
D
20602
D
Common Stock
82928
I
See Footnote
Stock Option (Right to Buy)
1.43
2014-10-02
4
M
0
5809
0
D
2017-01-11
Common Stock
5809
56277
D
Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 13, 2014.
Includes 20,000 restricted stock units. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) restricted stock unit.
The shares are held by John Allan Lewicki and Jenniffer Joan Lewicki, Trustees of the Lewicki Family Trust dated December 6, 2000.
The option is fully vested and exercisable, subject to an annual limitation of 175,438 shares that can be issued to a single grantee upon the exercise of awards under the Issuer's 2004 Stock Incentive Plan.
/s/ Alicia J. Hager, Attorney-in-Fact for John A. Lewicki
2014-10-03